Supplementary Figure S2 from Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy from a First-in-Human Study of Volrustomig, a Novel PD-1/CTLA-4 Bispecific Antibody

作者：Ben Tran, Mark Voskoboynik, Sang‐We Kim, Charlotte Lemech, Enric Carcereny, Sun Young Rha, Myung‐Ju Ahn, Enriqueta Felip, Ki Hyeong Lee, Eduardo Castañón Álvarez, James Chih‐Hsin Yang, Paolo A. Ascierto, Mariano Provencio, Shunsuke Kondo, Yasutoshi Kuboki, Daniel Freeman, Xuyang Song, Jorge Blando, Steven Eck, Florian Song, Zoey Tang, Michael Kuziora, Shelby D. Gainer, Patrick Mitchell, Julie M. Asare, Amal Ayyoub, Ikbel Achour, Deepa S. Subramaniam, Seock‐Ah Im · 年份：2026 · DOI：10.1158/1078-0432.33014556 · 研究领域：Medicine、Cancer research、Immunology、Chemistry、Molecular biology

<p>Supplementary Figure S2. PD-1 receptor occupancy on CD8+ T cells over time.</p>